4//SEC Filing
Ramasastry Saira 4
Accession 0001547959-26-000002
CIK 0001759425other
Filed
Jan 15, 7:00 PM ET
Accepted
Jan 16, 4:05 PM ET
Size
8.4 KB
Accession
0001547959-26-000002
Insider Transaction Report
Form 4
Ramasastry Saira
Director
Transactions
- Exercise/Conversion
Common Stock
2026-01-15$23.51/sh+2,000$47,020→ 2,000 total - Sale
Common Stock
[F1]2026-01-15$90.99/sh−2,000$181,980→ 0 total - Exercise/Conversion
Stock Option (right to buy)
[F2]2026-01-15−2,000→ 8,000 totalExercise: $23.51Exp: 2032-06-01→ Common Stock (2,000 underlying)
Footnotes (2)
- [F1]Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on September 18, 2025.
- [F2]The stock option is fully vested.
Signature
/s/ Judit Ryvkin, Attorney-in-Fact|2026-01-15
Documents
Issuer
Mirum Pharmaceuticals, Inc.
CIK 0001759425
Entity typeother
Related Parties
1- filerCIK 0001547959
Filing Metadata
- Form type
- 4
- Filed
- Jan 15, 7:00 PM ET
- Accepted
- Jan 16, 4:05 PM ET
- Size
- 8.4 KB